Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07443618
Eligibility Criteria:
Inclusion Criteria (Outpatient breast cancer patients with lymphoedema after radiotherapy):
* Habile
* Must be able to speak and read Danish
* Has received/is receiving radiotherapy due to breast cancer within the last 6 months
* Is being followed in the Oncology Outpatient Clinic at Aalborg University Hospital
* Age ≥ 18 years
* Visible lymphoedema in at least one upper extremity
Inclusion Criteria (Hospitalized cancer patients with peripheral oedema in one or both lower extremities after chemotherapy):
* Habile
* Must be able to speak and read Danish
* Has received/is receiving chemotherapy due to cancer within the last 2 months
* Hospitalised in the Oncology Ward at Aalborg University Hospital
* Estimated length of hospital stay of at least 6 days
* Age ≥ 18 years
* Visible peripheral oedema in at least one lower extremity
Exclusion Criteria (both groups):
* Pregnant or breastfeeding women
* Amputated limb(s)
* Pacemaker or implanted cardioverter-defibrillator due to risk of interference from the electrical signal
* Metallic prostheses due to risk of interference with the device signal
* Inability to lie still for the duration of the measurement interval (minimum 2 minutes at a time)
* Inability to stand on a scale, i.e. permanently bedridden.
* Inability to cooperate with urine collection
* Receiving dialysis
* Terminal illness
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07443618
Study Brief:
Protocol Section:
NCT07443618